Arrowhead Pharmaceuticals GAAP EPS of $0.22 beats by $0.37,...

2026-02-05 16:24:06 ET More on Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses Interim Results From Obesity Candidates and Advances in Treatment Approaches - Slideshow Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses Interim Results From Obesity Candidates and Advances in Treatment Approaches Transcript Arrowhead Pharmaceuticals Q1 2026 Earnings Preview Arrowhead Pharmaceuticals prices upsize convertible notes offering to $625M and stock offering at $64.50 Read the full article on Seeking Alpha For further details see: Arrowhead Pharmaceuticals GAAP EPS of $0.22 beats by $0.37, revenue of $264.03M beats by $33.18M